Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications: a meta-analysis

European Journal of Cardio-thoracic Surgery

Volumn 35, Issue 3, 2009, Pages 521-527

  Baker, William L ^a,c   Anglade, Moise W ^b,c   Baker, Erica L ^c   White, Charles Michael ^a,c   Kluger, Jeffrey ^b,c   Coleman, Craig I ^a,c  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^c HARTFORD HOSPITAL   (United States)

Author keywords

Antioxidant; Cardiac surgery; Cardiopulmonary bypass; Meta analysis; N acetylcysteine

Indexed keywords

ACETYLCYSTEINE; PLACEBO;

ACUTE KIDNEY FAILURE; ANTIOXIDANT ACTIVITY; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; DRUG USE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART SURGERY; HUMAN; LENGTH OF STAY; META ANALYSIS; OXIDATIVE STRESS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; STROKE; SYSTEMATIC REVIEW; THORAX SURGERY;

ACETYLCYSTEINE; CARDIOPULMONARY BYPASS; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; MALE; OXIDATIVE STRESS; POSTOPERATIVE COMPLICATIONS;

EID: 60949099470     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2008.11.027     Document Type: Review

References (42)

1. Starkopf J., Zilmer K., Vihalemm T., Kullisaar T., Zilmer M., and Samarütel J. Time course of oxidative stress during open-heart surgery. Scand J Thorac Cardiovasc Surg 29 (1995) 181-186
2. Paparella D., Yau T.M., and Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 21 (2002) 232-244
3. Chaney M.A. Corticosteroids and cardiopulmonary bypass: a review of clinical investigations. CHEST 121 (2002) 921-931
4. Goettea A., and Lendeckel U. Nonchannel drug targets in atrial fibrillation. Pharmacol Ther 102 (2004) 17-36
5. Bruins P., te Velthuis H., Yazdanbakhsh A.P., Jansen P.G.M., van Hardevelt F.W.J., de Beaumont E.M.F.H., Wildevuur C.R.H., Eijsman L., Trouwborst L., and Hack C.E. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 96 (1997) 3542-3548
6. Gaudino M., Andreotti F., Zamparelli R., Di Castelnuovo A., Nasso G., Burzotta F., Iacoviello L., Donati M.B., Schiavello R., Maseri A., and Possati G. The 174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication?. Circulation 108 (2003) 195-199
7. Forman M.B., Puett D.W., Cates C.U., McCroskey D.E., Beckman J.K., Greene H.L., and Virmani R. Glutathione redox pathway and reperfusion injury. Effect of N-acetylcysteine on infarct size and ventricular function. Circulation 78 (1988) 202-213
8. Sochman J., Kolc J., Vrana M., and Fabian J. Cardioprotective effects of N-acetylcysteine: the reduction in the extent of infarction and occurrence of reperfusion arrhythmias in the dog. Int J Cardiol 28 (1990) 191-196
9. Baliga R., Ueda N., Walker P.D., and Shaw S.W. Oxidant mechanisms in toxic acute renal failure. Am J Kidney Dis 29 (1997) 465-477
10. Neuman R.B., Bloom H.L., Shukrullah I., Darrow L.A., Kleinbaum D., Jones D.P., and Dudley S.C. Oxidative stress markers are associated with persistent atrial fibrillation. Clin Chem 53 (2007) 1652-1657
11. Ramlawi R., Out H., Mieno S., Boodhwani M., Sodha N.R., Clements R.T., Bianchi C., and Sellke F.W. Oxidative stress and atrial fibrillation after cardiac surgery: a case-control study. Ann Thorac Surg 84 (2007) 1166-1173
12. McColl A.J., Keeble T., Hadjinikolaou L., Cohen A., Aitkenhead H., Glenville B., and Richmond W. Plasma antioxidants: evidence for a protective role against reactive oxygen species following cardiac surgery. Ann Clin Biochem 35 (1998) 616-623
13. Tossios P., Bloch W., Huebner A., Raji M.R., Dodos F., Klass O., Suedkamp M., Kasper S.M., Hellmich M., and Mehlhorn U. N-acetylcysteine prevents reactive oxygen species-mediated myocardial stress in patients undergoing cardiac surgery: results of a randomized, double-blind, placebo-controlled trial. J Thorac Cardiovasc Surg 126 (2003) 1513-1520
14. Fischer U.M., Tossios P., Huebner A., Geissler H.J., Bloch W., and Mehlhorn U. Myocardial apoptosis prevention by radical scavenging in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 128 (2004) 103-108
15. Sucu N., Cinel I., Unlu A., Aytacoglu B., Tamer L., Kocak Z., Karaca K., Gul A., Dikmengil M., Atik U., and Oral U. N-acetylcysteine for preventing pump-induced oxidoinflammatory response during cardiopulmonary bypass. Surg Today 34 (2004) 237-242
16. Baker W.L., White C.M., Kluger J., Denowitz A., Konecny C.P., and Coleman C.I. Effect of perioperative corticosteroid use on the incidence of postcardiothoracic surgery atrial fibrillation and length of stay. Heart Rhythm 4 (2007) 461-468
17. Lertsburapa K., White C.M., Kluger J., Faheem O., Hammond J., and Coleman C.I. Preoperative statins for the prevention of atrial fibrillation after cardiothoracic surgery. J Thorac Cardiovasc Surg 135 (2008) 405-411
18. Patti G., Chello M., Candura D., Pasceri V., D'Ambrosio A., Covino E., and Di Sciascio G. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery. Circulation 114 (2006) 1455-1461
19. Arfsten D., Johnson E., Thitoff A., Jung A., Wilfong E., Lohrke S., Bausman T., Eggers J., and Bobb A. Impact of 30-day oral dosing with N-acetyl-L-cysteine on Sprague-Dawley rat physiology. Int J Toxicol 23 (2004) 239-247
20. Orhan G., Yapici N., Yuksel M., Sargin M., Senay S., Yalcin A.S., Aykac Z., and Aka S.A. Effects of N-acetylcysteine on myocardial ischemia-reperfusion injury in bypass surgery. Heart Vessels 21 (2006) 42-47
21. Eren N., Cakir O., Oruc A., Kaya Z., and Erdinc L. Effects of N-acetylcysteine on pulmonary function in patients undergoing coronary artery bypass surgery with cardiopulmonary bypass. Perfusion 18 (2003) 345-350
22. Haase M., Haase-Fielitz A., Bagshaw S.M., Reade M.C., Morgera S., Seevenayagam S., Matalanis G., Buxton B., Doolan L., and Bellomo R. Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients. Crit Care Med 35 (2007) 1324-1331
23. El-Hamamsy I., Stevens L.M., Carrier M., Pellerin M., Bouchard D., Demers P., Cartier R., Page P., and Perrault L.P. Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. J Thorac Cardiovasc Surg 133 (2007) 7-12
24. Wijeysundera D.N., Beattie W.S., Rao V., Granton J.T., and Chan C.T. N-acetylcysteine for preventing acute kidney injury in cardiac surgery patients with pre-existing moderate renal insufficiency. Can J Anesth 54 (2007) 872-881
25. Ozaydin M., Peker O., Erdogan D., Kapan S., Turker Y., Varol E., Ozguner F., Dogan A., and Ibrisim E. N-acetylcysteine for prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study. Eur Heart J 29 (2008) 625-631
26. Burns K.E., Chu M.W., Novick R.J., Fox S.A., Gallo K., Martin C.M., Stitt L.W., Heidenheim A.P., Myers M.L., and Moist L. Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing CABG surgery: a randomized controlled trial. JAMA 294 (2005) 342-350
27. Ristikankare A., Kuitunen T., Kuitunen A., Uotila L., Vento A., Suojaranta-Ylinen R., Salmenperä M., and Pöyhiä R. Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery. Br J Anaesth 97 (2006) 611-616
28. Sisillo E., Ceriani R., Bortone F., Juliano G., Salvi L., Veglia F., Fiorentini C., and Marenzi G. N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial. Crit Care Med 36 (2008) 81-86
29. Adabag A.S., Ishani A., Koneswaran S., Johnson D.J., Kelly R.F., Ward H.B., McFalls E.O., Bloomfield H.E., and Chandrashekhar Y. Utility of N-acetylcysteine to prevent acute kidney injury after cardiac surgery: a randomized controlled trial. Am Heart J 155 (2008) 1143-1149
30. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]. In: The Cochrane Library, Issue 4. Chichester, UK: John Wiley & Sons, Ltd.; 2006
31. Mathew J.P., Fontes M.L., Tudor I.C., Ramsay J., Duke P., Mazer C.D., Barash P.G., Hsu P.H., and Mangano D.T. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 291 (2004) 1720-1729
32. Maisel W.H., Rawn J.D., and Stevenson W.G. Atrial fibrillation after cardiac surgery. Ann Intern Med 135 (2001) 1061
33. Eslami M., Badkoubeh R.S., Mousavi M., Radmehr H., Salehi M., Tavakoli N., and Avadi M.R. Oral ascorbic acid in combination with beta-blockers is more effective than beta-blockers alone in the prevention of atrial fibrillation after coronary artery bypass grafting. Tex Heart Inst J 34 (2007) 268-274
34. Zanardo G., Michielon P., Paccagnella A., Rosi P., Caló M., Salandin V., Da Ros A., Michieletto F., and Simini G. Acute renal failure in the patient undergoing cardiac operation: prevalence, mortality rate and main risk factors. J Thorac Cardiovasc Surg 107 (1994) 1489-1495
35. Lassnigg A., Schmidlin D., Mousieddine M., Bachmann L.M., Druml W., Bauer P., and Hiesmayr M. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 15 (2004) 1597-1605
36. Birck R., Krzossok S., Markowetz F., Schnülle P., van der Woude F.J., and Braun C. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 362 (2003) 598-603
37. Ho K.M., and Morgan D.J. Meta-analysis of n-acetylcysteine to prevent acute renal failure after major surgery. Am J Kidney Dis 53 (2009) 33-40
38. Kelly G.S. Clinical applications of N-acetylcysteine. Alt Med Rev 3 (1998) 114-127
39. Anderson L.W., Thiis J., Kharazmi A., and Rygg I. The role of N-acetylcysteine administration on the oxidative response of neutrophils during cardiopulmonary bypass. Perfusion 10 (1995) 21-26
40. Zhu J., Yin R., Shao H., Dong G., Luo L., and Jing H. N-acetylcysteine to ameliorate acute renal injury in a rat cardiopulmonary bypass model. J Thorac Cardiovasc Surg 133 (2007) 696-703
41. Fuster V., Rydén L.E., Cannom D.S., Crijns H.J., Curtis A.B., Ellenbogen K.A., Halperin J.L., Le Heuzey J.-Y., Kay G.N., Lowe J.E., Olsson S.B., Prystowsky E.N., Tamargo J.L., Wann S., Smith S.C., Jacobs A.K., Adams C.D., Anderson J.L., Antman E.M., Hunt S.A., Nishimura R., Ornato J.P., Page R.L., Riegel B., Priori S.G., Blanc J.-J., Budaj A., Camm A.J., Dean V., Deckers J.W., Despres C., Dickstein K., Lekakis J., McGregor K., Metra M., Morais J., Osterspey A., and Zamorano J.L. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). J Am Coll Cardiol 48 (2006) e149-246
42. Baker W.L., and White C.M. Post-cardiothoracic surgery atrial fibrillation: a review of preventive strategies. Ann Pharmacother 41 (2007) 587-598